Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

ECMO kidney care: one line or two?

NCT ID NCT06038162

Knowledge-focused Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two methods for providing kidney dialysis to patients on ECMO (a heart-lung machine). One method uses a separate line for dialysis, while the other connects the dialysis machine directly into the ECMO circuit. The goal is to see if the direct connection works just as well, possibly reducing infections and bleeding. About 158 adults on ECMO who need kidney therapy will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this trial succeeds, it could show that connecting kidney therapy directly into the ECMO circuit is just as effective as using a separate line, potentially reducing complications.
What could go wrong
This is a relatively small, early-stage trial focused on equipment performance, not a new drug or cure. The results may not change practice if the integrated method causes safety issues like air bubbles or clotting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 158 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged above 18 years * Patient on VA-ECMO who requires the initiation of continuous RRT during VA-ECMO treatment * Patient with a foreseeable length of stay in intensive care greater than 24 hours Exclusion Criteria: * Patient who does not have a vascular capital allowing for the insertion of a new dialysis catheter to administer RRT and therefore cannot be randomized to the parallel connection group * High pressures monitored on ECMO not allowing direct RRT catherter on ECMO * Pregnant, parturient, or breastfeeding women * Patient deprived of liberty by a judicial or administrative decision * Patient under psychiatric care * Patient subject to a legal protection measure (guardianship, curators) * Patient not affiliated to a social security system * Patient participating in another interventional research study in the field of extra purification renal

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute kidney injury are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute kidney injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute kidney injury Renal replacement therapy Venoarterial extracorporeal membrane oxygenation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    12 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • APHP, Institut de Cardiologie, Service d'anesthésie-réanimation cardiovasculaire, Hôpital de la Pitié-Salpêtrière

    RECRUITING

    Paris, France

  • APHP, Institut de cardiologie, Service de Médecine Intensive Réanimation, Hôpital Pitié-Salpêtrière

    RECRUITING

    Paris, France

  • CHU de Bordeaux, GH Sud, Service d'anesthésie-réanimation cardiovasculaire, Hôpital cardiologique

    RECRUITING

    Bordeaux, France

  • CHU de Clermont Ferrand, Pôle de médecine péri-opératoire/Chirurgie cardiaque, Hôpital Gabriel Montpied

    RECRUITING

    Clermont-Ferrand, France

  • CHU de Grenoble, Service de réanimation cardiovasculaire et thoracique, Pôle anesthésie réanimation, Hôpital Nord

    RECRUITING

    Grenoble, France

  • CHU de Montpellier, Département d'anesthésie-réanimation, Pôle Cœur-poumons, Hôpital Arnaud de Villeneuve

    RECRUITING

    Montpellier, France

  • CHU de Saint Etienne, Hôpital Bellevue, Service de Réanimation polyvalente et soins intensifs post-opératoires

    RECRUITING

    Saint-Etienne, France

  • Centre Hospitalo Universitaire de Dijon, Unité Réanimation Cardio-Vasculaire,

    RECRUITING

    Dijon, 21079, France

  • Centre Hospitalo Universitaire de Lille, Institut Coeur Poumon

    NOT_YET_RECRUITING

    Lille, 59037, France

  • Centre Hospitalo Universitaire de Toulouse, Hôpital Rangueil - Réanimation polyvalente

    NOT_YET_RECRUITING

    Toulouse, 31059, France

  • Centre Hospitalo Universitaire de Toulouse, Unité de Chirurgie Cardiaque

    NOT_YET_RECRUITING

    Toulouse, 31059, France

  • Hospices Civils de Lyon, Service d'Anesthésie-Réanimation cardiovasculaire, Hôpital Louis Pradel

    RECRUITING

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.